Work

Abstract 4368890: Cholesteryl Ester Transfer Protein (CETP) Inhibition with Obicetrapib Produces Substantial Reductions in LDL Particles: Pooled Analysis of BROOKLYN and BROADWAY Phase 3 Clinical Trials

Year: 2025

Type: conference-abstract

Source: Circulation

DOI: 10.1161/circ.152.suppl_3.4368890

Authors: Michael Davidson, Stephen Nicholls, Kausik Ray, Marc Ditmarsch, Douglas Kling, Danielle Curcio, Erin Wuerdeman, Andrew Hsieh, John Kastelein

Institutions: NewAmsterdam Pharma (Netherlands), Victorian Heart Hospital, Imperial College London

Language: English

Topic: Lipoproteins and Cardiovascular Health

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415791061

Cites:

Cited by: 1

Related to: